Tilray Brands (TLRY) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
28 Sep, 2026Executive summary
Annual Meeting scheduled for November 18, 2026, will be held virtually, allowing shareholders to vote and ask questions online.
Key proposals include electing three Class II directors, ratifying the auditor, and approving governance changes to declassify the Board and allow director removal without cause.
Board emphasizes focus on strategic priorities, business strengthening, and long-term shareholder value.
Voting matters and shareholder proposals
Shareholders will vote on electing David Clanachan, Renah Persofsky, and Irwin Simon as Class II directors for terms expiring in 2029.
Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending May 31, 2027.
Approval sought for governance changes: declassifying the Board and allowing removal of directors without cause.
Board recommends voting FOR all proposals.
Board of directors and corporate governance
Board consists of seven members, with a mix of independent and non-independent directors.
Governance Proposal aims to move from a classified to an annually elected Board, increasing accountability.
Board diversity highlighted, with 14.3% female directors and a range of backgrounds and expertise.
Board leadership combines CEO and Chair roles, with a separate independent Vice Chair to enhance communication.
All directors attended at least 75% of meetings in FY 2026.
Latest events from Tilray Brands
- Key votes include board declassification, annual director elections, and auditor ratification.TLRY
Proxy filing - Virtual meeting to vote on board declassification, director elections, and auditor ratification.TLRY
Proxy filing - Record revenue and adjusted EBITDA highlight strong growth and international expansion.TLRY
Q4 2026 - Record Q3 revenue, improved profitability, and strong international cannabis growth.TLRY
Q3 2026 - Acquisition creates a $500M global craft beverage platform, driving EBITDA and international growth.TLRY
M&A announcement - Record Q2 revenue, improved cash flow, and strong cannabis and distribution growth boost outlook.TLRY
Q2 2026 - Record revenue growth, margin gains, and cost synergies support a strong FY2025 outlook.TLRY
Q4 2024 - Q3 net revenue was $185.8M, with improved margins but a $793.5M net loss from impairments.TLRY
Q3 2025 - Q2 revenue hit $211M (+9% YoY), with margin gains and Project 420 synergies driving growth.TLRY
Q2 2025